Advertisement
Screener

Heartflow, Inc. (HTFL) Cash and Cash Equivalents, Fair Value Disclosure

Heartflow, Inc. Cash and Cash Equivalents, Fair Value Disclosure

Heartflow, Inc. (HTFL) had Cash and Cash Equivalents, Fair Value Disclosure of $263.00 million as of 2025-09-30, per its 10-Q filed 2025-11-12.

Financial Statements › Notes › Fair Value Disclosures

us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2025-11-12

  • 2025-09-30: Cash and Cash Equivalents, Fair Value Disclosure $263.00M.
  • 2025-06-30: Cash and Cash Equivalents, Fair Value Disclosure $51.89M.
  • 2024-12-31: Cash and Cash Equivalents, Fair Value Disclosure $36.88M.
Period endCash and Cash Equivalents, Fair Value Disclosure
2025-09-30$263.00M
10-Q · filed 2025-11-12
2025-06-30$51.89M
10-Q · filed 2025-09-19
2024-12-31$36.88M
10-Q · filed 2025-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
HAEMONETICS CORP (HAE)United States$4.821B36.52
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
AtriCure, Inc. (ATRC)United States$3.089B
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55